S035 Challenging Adult and Pediatric Autoimmune Connective Tissue Disease Cases: Pearls for Diagnosis and Management
DESCRIPTION
Using clinical cases, classic and atypical presentations of cutaneous manifestations of autoimmune connective tissue diseases will be emphasized. This session will offer practical tips for diagnosis, appropriate evaluation, and advanced therapeutic management of both adult and pediatric patients with connective tissue diseases affecting the skin. Audience self-assessment will be encouraged through image review, and a case-based approach will be utilized to highlight relevance for the dermatology trainee or experienced clinician. Cases discussed will include those focusing on dermatomyositis, cutaneous lupus erythematosus, systemic sclerosis, eosinophilic fasciitis, and morphea, amongst others.
LEARNING OBJECTIVES
Identify and diagnose classic and atypical presentations of cutaneous manifestations of autoimmune connective tissue diseases in both adults and children.
Select management options for skin involvement in complex connective tissue diseases based on the best available evidence from the literature.
SCHEDULE
1:00 PM
Intro
Ruth Ann Vleugels, MPH, MD, MBA, FAAD
1:05 PM
Challenging Autoimmune Connective Tissue Disease Cases
Alisa Femia, MD, FAAD
1:16 PM
Challenging Autoimmune Connective Tissue Disease Cases
Kimberly V Hashemi, MD
1:27 PM
Challenging Autoimmune Connective Tissue Disease Cases
Christina Lam, MD, FAAD
1:38 PM
Challenging Autoimmune Connective Tissue Disease Cases
Jennifer Yeh, PhD, MD, FAAD
1:49 PM
Challenging Autoimmune Connective Tissue Disease Cases
Katharina Stephanie Shaw, MD, FAAD
2:00 PM
Challenging Autoimmune Connective Tissue Disease Cases
Dustin Taylor, MD, FAAD
2:11 PM
Challenging Autoimmune Connective Tissue Disease Cases
Jeffrey R Gehlhausen, MD, PhD, FAAD
2:22 PM
Q&A
2:33 PM
Challenging Autoimmune Connective Tissue Disease Cases
Gabriela Andrea Cobos, MD, FAAD
2:44 PM
Challenging Autoimmune Connective Tissue Disease Cases
Rochelle Castillo, MD, MS
2:55 PM
Challenging Autoimmune Connective Tissue Disease Cases
Neda Shahriari, MD, FAAD
3:06 PM
Challenging Autoimmune Connective Tissue Disease Cases
Daniel Mazori, MD, FAAD
3:17 PM
Challenging Autoimmune Connective Tissue Disease Cases
Sarah Lonowski, MD, MBA, FAAD
3:28 PM
Challenging Autoimmune Connective Tissue Disease Cases
Avery H LaChance, MPH, MD, FAAD
3:39 PM
Challenging Autoimmune Connective Tissue Disease Cases
Ruth Ann Vleugels, MPH, MD, MBA, FAAD
3:50 PM
Q&A
DIRECTOR
Ruth Ann Vleugels, MPH, MD, MBA, FAAD
SPEAKERS
Rochelle Castillo, MD, MS
Gabriela Andrea Cobos, MD, FAAD
Alisa Femia, MD, FAAD
Jeffrey R Gehlhausen, MD, PhD, FAAD
Kimberly V Hashemi, MD
Avery H LaChance, MPH, MD, FAAD
Christina Lam, MD, FAAD
Sarah Lonowski, MD, MBA, FAAD
Daniel Mazori, MD, FAAD
Neda Shahriari, MD, FAAD
Katharina Stephanie Shaw, MD, FAAD
Dustin Taylor, MD, FAAD
Jennifer Yeh, PhD, MD, FAAD
DISCLOSURES
Rochelle Castillo, MD, MS
Johnson & Johnson Innovative Medicine – Advisory Board(Honoraria); Priovant Therapeutics – Consultant (1099 relationship)(Fees);
Gabriela Andrea Cobos, MD, FAAD
AbbVie – Speaker(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Biogen – Investigator(Honoraria); Bristol Myers Squibb – Speaker/Faculty Education(Fees); Bristol-Myers Squibb – Advisory Board(Honoraria); Dermira/Lilly – Advisory Board(Honoraria), Speaker/Faculty Education(Fees); Incyte – Advisory Board(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Speaker(Fees); Octapharma – Consultant (1099 relationship)(Fees); Priovant Therapeutics – Advisory Board(Fees); Sanofi/Regeneron – Advisory Board(Honoraria), Speaker(Fees); UCB – Advisory Board(Honoraria);
Alisa Femia, MD, FAAD
No financial relationships exist with ineligible companies.
Jeffrey R Gehlhausen, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Kimberly V Hashemi, MD
No financial relationships exist with ineligible companies.
Avery H LaChance, MPH, MD, FAAD
atheneum – Consultant (1099 relationship)(Fees); Biogen – Advisory Board(Fees); Guidepoint Global, LLC – Consultant (1099 relationship)(Fees); Johnson & Johnson Consumer, Inc. – Advisory Board(Honoraria); MEDACorp – Consultant (1099 relationship)(Fees); Merck – Investigator(Grants/Research Funding); Pfizer Inc. – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Priovant Therapeutics – Advisory Board(Fees); TD Cowen – Speaker(Honoraria);
Christina Lam, MD, FAAD
Biogen – Consultant (1099 relationship)(Fees), Investigator(Fees); Priovant Therapeutics – Advisory Board(Fees);
Sarah Lonowski, MD, MBA, FAAD
AstraZeneca – Investigator(Grants/Research Funding); Bristol Myers Squibb – Other(Other Financial Benefit); Eli Lilly – Investigator(Grants/Research Funding); Priovant Therapeutics – Advisory Board(No Compensation Received); Veradermics – Consultant (1099 relationship)(Fees);
Daniel Mazori, MD, FAAD
Veradermics – Advisory Board(Fees);
Neda Shahriari, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria); AstraZeneca – Investigator(Grants/Research Funding); Biogen – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Incyte – Consultant (1099 relationship)(Honoraria); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant (1099 relationship)(Honoraria);
Katharina Stephanie Shaw, MD, FAAD
Priovant – Employee (w-2 relationship)(Salary);
Dustin Taylor, MD, FAAD
No financial relationships exist with ineligible companies.
Ruth Ann Vleugels, MPH, MD, MBA, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Astra Zeneca – Consultant (1099 relationship)(Honoraria); Biogen – Consultant (1099 relationship)(Honoraria); BMS – Consultant (1099 relationship)(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria);
Jennifer Yeh, PhD, MD, FAAD
No financial relationships exist with ineligible companies.